Onychomycosis: Therapeutic update

Journal of the American Academy of Dermatology

Volumn 40, Issue 6 II, 1999, Pages

  Scher, R K ^a  

^a New York Presbyterian Hospital Columbia University Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE; ITRACONAZOLE; NEW DRUG; TERBINAFINE;

CONFERENCE PAPER; DERMATOPHYTE; DOSE RESPONSE; DRUG CHOICE; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; MOULD; NONHUMAN; ONYCHOMYCOSIS; ORAL DRUG ADMINISTRATION; PATIENT ATTITUDE; PATIENT COMPLIANCE; PREVALENCE; PRIORITY JOURNAL; PRURITUS; RASH; RHINITIS; TRICHOPHYTON MENTAGROPHYTES; TRICHOPHYTON RUBRUM; YEAST;

EID: 0033056639     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0190-9622(99)70397-x     Document Type: Conference Paper

References (20)

1. BE Elewski MA Charif CR Daniel III Onychomycosis 2nd ed RK Scher CR Daniel III Nails: diagnosis, treatment, surgery 1997 WB Saunders Philadelphia 151 162
2. MM Chiritescu M-E Chiritescu RK Scher Newer systemic antifungal drugs for the treatment of onychomycosis Clin Podiatr Med Surg 13 1996 741 758
3. BE Elewski RJ Hay Update on the management of onychomycosis: highlights on the Third Annual International Summit in Cutaneous Antifungal Therapy Clin Infect Dis 23 1996 305 313
4. BE Elewski Once-weekly fluconazole in the treatment of onychomycosis J Am Acad Dermatol 38 1998 S73 S76
5. RK Scher Onychomycosis is more than a cosmetic problem Br J Dermatol 130 suppl 1994 15
6. DP Lubeck DL Patrick P McNulty SK Fifer J Birnbaum Quality of life of persons with onychomycosis Qual Life Res 2 1993 341 348
7. LA Drake RK Scher EB Smith Effect of onychomycosis on quality of life J Am Acad Dermatol 38 1998 702 704
8. P Rich RK Scher D Breneman Pharmacokinetics of three doses of once-weekly fluconazole (150, 300, and 450 mg) in the treatment of distal subungual onychomycosis of the toenail J Am Acad Dermatol 38 1998 S103 S109
9. AK Gupta RK Scher P De Doncker Current management of onychomycosis: an overview Dermatol Clin 15 1997 121 135
10. W Meinhof Kinetics and spectrum of activity of oral antifungals: the therapeutic implications J Am Acad Dermatol 29 1993 S37 S41
11. P DeDoncker J Decroix GE Piérard Antifungal pulse therapy for onychomycosis: a pharmacokinetic and pharmacodynamic investigation of monthly cycles of 1-week pulse therapy with itraconazole Arch Dermatol 132 1996 34 41
12. E Epstein How often does oral treatment of toenail onychomycosis produce a disease-free nail? An analysis of published data Arch Dermatol 134 1998 1551 1554
13. Sporanox® (itraconazole) 100 mg capsules: package insert. Titusville (NJ): Janssen Pharmaceutica Inc.
14. RJ Hay Onychomycosis: agents of choice Dermatol Clin 11 1993 161 169
15. RK Scher D Breneman P Rich A placebo-controlled, randomized, double-blind trial of once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the toenail J Am Acad Dermatol 38 1998 S77 S86
16. Diflucan® (fluconazole tablets). Package insert. New York: Pfizer Inc.
17. RR Assaf BE Elewski Intermittent fluconazole dosing in patients with onychomycosis J Am Acad Dermatol 35 1996 216 219
18. F Montero-Gei ME Robles-Soto H Schlager Fluconazole treatment of severe onychomycosis Int J Dermatol 35 1996 587 588
19. JE Fräki HT Heikkilä MO Kero An open-label, noncomparative, multicenter evaluation of fluconazole with or without urea nail pedicure for the treatment of onychomycosis Curr Ther Res 58 1997 481 491
20. Lamisil® (terbinafine hydrochloride tablets). Package insert. East Hanover (NJ): Novartis Pharmaceuticals Corporation.